ACADIA Pharmaceuticals, Inc. to Present at the Cowen and Company 33rd Annual Health Care Conference on March 4, 2013
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will present at the Cowen and Company 33rd Annual Health Care Conference on Monday, March 4, 2013, at 1:30 p.m. Eastern Time at the Boston Marriott Copley Place.